A score that is used to predict the survival of patients with advanced kidney cancer based on clinical and laboratory information; for example, time from diagnosis to start of drug treatment, Karnofsky performance status, levels of calcium and haemoglobin in the blood etc. Patients with advanced kidney cancer are classified into poor, intermediate and favourable risk categories based on their clinical and laboratory findings.

Share this Post!